HFP
SGYP

Holistic Financial Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Holistic Financial Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-195
Closed – – 416
2018
Q1 		$0 Hold
195
– – ﹤0.01% 466
2017
Q4 		$0 Buy
+195
New +$485 ﹤0.01% 450

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Holistic Financial Partners's SGYP Position: Q2 2018 in Review

Holistic Financial Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 195 shares.

Holistic Financial Partners first reported a position in SGYP in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q1 2018. 136 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

  • Holistic Financial Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
  • Holistic Financial Partners sold 195 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018.
  • Holistic Financial Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 2 quarters.
  • Holistic Financial Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2018.
  • 136 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on Holistic Financial Partners's 13F filing for Q2 2018, filed 14 Aug 2018.